Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

Affiliations

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
² Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
³ St John's Institute of Dermatology within the, School of Basic & Medical Biosciences, King's College London, London, UK.
⁴ NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁵ Hair Restoration Blackrock, Dublin, Ireland.
⁶ National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, Dublin, Ireland.
⁷ Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
⁸ Department of Dermatology, Aarhus University Hospital, Aarhus C, Denmark.
⁹ Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
¹⁰ Clinical Medicine, Trinity College Dublin, Dublin, Ireland.

S K Mahil et al. Br J Dermatol. 2020 Aug.

. 2020 Aug;183(2):404-406.

doi: 10.1111/bjd.19161. Epub 2020 Jun 10.

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
² Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
³ St John's Institute of Dermatology within the, School of Basic & Medical Biosciences, King's College London, London, UK.
⁴ NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁵ Hair Restoration Blackrock, Dublin, Ireland.
⁶ National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, Dublin, Ireland.
⁷ Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
⁸ Department of Dermatology, Aarhus University Hospital, Aarhus C, Denmark.
⁹ Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
¹⁰ Clinical Medicine, Trinity College Dublin, Dublin, Ireland.

No abstract available

References

1. Cao X. COVID‐19: immunopathology and its implications for therapy. Nat Rev Immunol 2020; 20:269–70. - PMC - PubMed
1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323:1239–42. - PubMed
1. Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol 2016; 38:11–27. - PMC - PubMed
1. Weidinger S, Beck LA, Bieber T et al. Atopic dermatitis. Nat Rev Dis Primers 2018; 4:1. - PubMed
1. Kalb RE, Fiorentino DF, Lebwohl MG et al. Risk of serious infection with biologic and systemic treatment of psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol 2015; 151:61–9. - PubMed